Menu

Filtros : "Lancet" "2008" Limpar

Filtros

Refine with date range

  • 1

1 - 3 (3 records)

  • Artigo de periodico

    Effects extended release metoprolol succinate in patients undergoing non cardiac surgery (POISE trial): a randomised controlled trial (2008)

    Marin-Neto, José Antônio

    Source: Lancet. Unidade: FMRP

    Assunto: CARDIOLOGIA (CIRURGIA)

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      MARIN-NETO, José Antônio. Effects extended release metoprolol succinate in patients undergoing non cardiac surgery (POISE trial): a randomised controlled trial. Lancet, v. 371, n. 9627, p. 1839-1847, 2008Tradução . . Acesso em: 31 ago. 2024.

    • APA

      Marin-Neto, J. A. (2008). Effects extended release metoprolol succinate in patients undergoing non cardiac surgery (POISE trial): a randomised controlled trial. Lancet, 371( 9627), 1839-1847.

    • NLM

      Marin-Neto JA. Effects extended release metoprolol succinate in patients undergoing non cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008 ; 371( 9627): 1839-1847.[citado 2024 ago. 31 ]

    • Vancouver

      Marin-Neto JA. Effects extended release metoprolol succinate in patients undergoing non cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008 ; 371( 9627): 1839-1847.[citado 2024 ago. 31 ]

  • Artigo de periodico

    Effects of the angiotensin receptor blocker telmisartan on cardiovascular events in high-rish patients intolerant to angiotensin converting enzyme inhibitors: a randomised controlled trial (2008)

    Marin-Neto, José Antônio

    Source: Lancet. Unidade: FMRP

    Subjects: DOENÇAS CARDIOVASCULARES, ANGIOTENSINAS

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      MARIN-NETO, José Antônio. Effects of the angiotensin receptor blocker telmisartan on cardiovascular events in high-rish patients intolerant to angiotensin converting enzyme inhibitors: a randomised controlled trial. Lancet, v. 372, n. 9644, p. 1174-1183, 2008Tradução . . Acesso em: 31 ago. 2024.

    • APA

      Marin-Neto, J. A. (2008). Effects of the angiotensin receptor blocker telmisartan on cardiovascular events in high-rish patients intolerant to angiotensin converting enzyme inhibitors: a randomised controlled trial. Lancet, 372( 9644), 1174-1183.

    • NLM

      Marin-Neto JA. Effects of the angiotensin receptor blocker telmisartan on cardiovascular events in high-rish patients intolerant to angiotensin converting enzyme inhibitors: a randomised controlled trial. Lancet. 2008 ; 372( 9644): 1174-1183.[citado 2024 ago. 31 ]

    • Vancouver

      Marin-Neto JA. Effects of the angiotensin receptor blocker telmisartan on cardiovascular events in high-rish patients intolerant to angiotensin converting enzyme inhibitors: a randomised controlled trial. Lancet. 2008 ; 372( 9644): 1174-1183.[citado 2024 ago. 31 ]

  • Artigo de periodico

    Renal outcomes with telmisartan, ramipril, or both, in people at high varcular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled (2008)

    Marin-Neto, José Antônio

    Source: Lancet. Unidade: FMRP

    Subjects: DOENÇAS CARDIOVASCULARES, INSUFICIÊNCIA RENAL, DOENÇAS CARDIOVASCULARES

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      MARIN-NETO, José Antônio. Renal outcomes with telmisartan, ramipril, or both, in people at high varcular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled. Lancet, v. 372, n. 9638, p. 547-553, 2008Tradução . . Acesso em: 31 ago. 2024.

    • APA

      Marin-Neto, J. A. (2008). Renal outcomes with telmisartan, ramipril, or both, in people at high varcular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled. Lancet, 372( 9638), 547-553.

    • NLM

      Marin-Neto JA. Renal outcomes with telmisartan, ramipril, or both, in people at high varcular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled. Lancet. 2008 ; 372( 9638): 547-553.[citado 2024 ago. 31 ]

    • Vancouver

      Marin-Neto JA. Renal outcomes with telmisartan, ramipril, or both, in people at high varcular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled. Lancet. 2008 ; 372( 9638): 547-553.[citado 2024 ago. 31 ]
  • 1

1 - 3 (3 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024